Compare MPV & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MPV | STXS |
|---|---|---|
| Founded | 1988 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.1M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | MPV | STXS |
|---|---|---|
| Price | $19.56 | $2.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 25.2K | ★ 699.9K |
| Earning Date | 01-01-0001 | 11-11-2025 |
| Dividend Yield | ★ 8.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.71 | N/A |
| Revenue | N/A | ★ $30,075,000.00 |
| Revenue This Year | N/A | $24.48 |
| Revenue Next Year | N/A | $29.98 |
| P/E Ratio | $9.35 | ★ N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $11.18 | $1.54 |
| 52 Week High | $16.42 | $3.59 |
| Indicator | MPV | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.62 | 45.45 |
| Support Level | $19.50 | $2.20 |
| Resistance Level | $20.21 | $2.46 |
| Average True Range (ATR) | 0.30 | 0.13 |
| MACD | -0.04 | 0.03 |
| Stochastic Oscillator | 7.35 | 78.02 |
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.